<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A review is given of the new Kiel classification of non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (NHL) and of the findings which led to its development </plain></SENT>
<SENT sid="1" pm="."><plain>The Kiel classification of NHL is based on morphological and immunological features shared by <z:mpath ids='MPATH_458'>normal</z:mpath> and neoplastic cells </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore, the origin, maturation, and reaction of nonneoplastic T- and B-cells together with their immunological, enzyme-cytochemical and morphological features are discussed first </plain></SENT>
<SENT sid="3" pm="."><plain>In the T-cell system T-precursor cells, prothymocytes, T1/T2-cells, and T-immunoblasts can be distinguished on the basis of the given features </plain></SENT>
<SENT sid="4" pm="."><plain>The B-system is primarily composed of cells of the two antigen-dependent B-cell reactions, the germinal center reaction, and the plasma cell reaction </plain></SENT>
<SENT sid="5" pm="."><plain>These cells can be distinguished both morphologically and through demonstration of the complement receptor in frozen sections </plain></SENT>
<SENT sid="6" pm="."><plain>We differentiate the following entities of NHL, divided into six groups for better understanding: 1. lymphocytic <z:hpo ids='HP_0002665'>lymphomas</z:hpo>: <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (CLL), prolymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo>, hairy cell <z:hpo ids='HP_0001909'>leukemia</z:hpo>, <z:e sem="disease" ids="C0026948" disease_type="Neoplastic Process" abbrv="">mycosis fungoides</z:e>, and <z:e sem="disease" ids="C0036920" disease_type="Neoplastic Process" abbrv="">Sézary syndrome</z:e>; 2. secretory immunoglobulin-producing <z:hpo ids='HP_0002665'>lymphomas</z:hpo>: <z:hpo ids='HP_0011857'>plasmacytoma</z:hpo> and <z:e sem="disease" ids="C0861199" disease_type="Neoplastic Process" abbrv="">lymphoplasmacytoid immunocytoma</z:e>; 3. germinal center cell <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>: <z:e sem="disease" ids="C1516391" disease_type="Neoplastic Process" abbrv="">centroblastic</z:e>/centrocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, centrocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, <z:e sem="disease" ids="C1516391" disease_type="Neoplastic Process" abbrv="">centroblastic</z:e> <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and <z:hpo ids='HP_0002665'>lymphoma</z:hpo> of the Burkitt type; 4. lymphoblastic <z:hpo ids='HP_0002665'>lymphomas</z:hpo>: "convoluted cell" type and "unclassified" type; 5. immunoblastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>; 6. reticulosarcoma </plain></SENT>
<SENT sid="7" pm="."><plain>B-cell characteristics are revealed by more than 80% of the NHL, namely by 97% of the cases of CLL, by <z:hpo ids='HP_0000001'>all</z:hpo> secretory immunoglobulin-producing <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, by <z:hpo ids='HP_0000001'>all</z:hpo> germinal center cell <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, and by most <z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>More than 50% of the B-cell <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> are evidently derived from germinal center cells </plain></SENT>
<SENT sid="9" pm="."><plain>The following are T-cell <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>: a few rare forms of CLL, <z:e sem="disease" ids="C0026948" disease_type="Neoplastic Process" abbrv="">mycosis fungoides</z:e> <z:e sem="disease" ids="C0036920" disease_type="Neoplastic Process" abbrv="">Sézary syndrome</z:e>, about 50% of the lymphoblastic <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, and a few <z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>It could be shown that the cells of lymphoblastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, "convolted cell" type with strong acid phosphatase reactivity have the same features as fetal thymocytes </plain></SENT>
<SENT sid="11" pm="."><plain>So far, we have not observed any cases of true <z:e sem="disease" ids="C0024302" disease_type="Neoplastic Process" abbrv="">reticulosarcoma</z:e> as described by Roulet and Rappaporti, i.e. <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> of phagocytic reticulum cells </plain></SENT>
<SENT sid="12" pm="."><plain>The morphological features which could be defined for the entities distinguished in the Kiel classification of NHL are so characteristic that most of these entities can now be diagnosed on the basis of their histological and cytological pictures alone </plain></SENT>
</text></document>